Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection
AbstractImproving early detection of lung cancer is critical to improving lung cancer survival. Studies have shown that computerized tomography (CT) screening can reduce mortality from lung cancer, but this involves risks of radiation exposure and can identify non-cancer lung nodules that lead to unnecessary interventions for some. There is a critical need to develop alternative, less invasive methods to identify patients who have early-stage lung cancer. The detection of circulating tumor cells (CTCs) are a promising area of research, but current technology is limited by a low yield of CTCs. Alternate studies are investigating circulating nucleic acids and proteins as possible tumor markers. It is critical to develop innovative methods for early lung cancer detection that may include CTCs or other markers that are low-risk and low-cost, yet specific and sensitive, to facilitate improved survival by diagnosing the disease when it is surgically curable. View Full-Text
Share & Cite This Article
Murlidhar, V.; Ramnath, N.; Nagrath, S.; Reddy, R.M. Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection. Cancers 2016, 8, 61.
Murlidhar V, Ramnath N, Nagrath S, Reddy RM. Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection. Cancers. 2016; 8(7):61.Chicago/Turabian Style
Murlidhar, Vasudha; Ramnath, Nithya; Nagrath, Sunitha; Reddy, Rishindra M. 2016. "Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection." Cancers 8, no. 7: 61.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.